Recent Posts

• SPIL Q1FY27 Financial Results
• Sun Pharma reports Q1FY27 results
• Sun Pharma receives approval to manufacture and market semaglutide in Brazil
• Sun Pharma launches generic semaglutide in South Africa
• Sun Pharma Notes Organon Shareholder Approval for Proposed Acquisition